G Protein News and Research

RSS

Distek launches BIOne benchtop scale single-use bioreactor system

From the company that has brought you 40 years of excellence in laboratory pharmaceutical instruments, Distek, Inc. is proud to introduce the BIOne Single-Use Bioreactor System.

20 May 2016

EAD therapy can shrink size of triple-negative breast cancer tumors in mice

In a new study using mice and lab-grown human cells, a scientific team led by Johns Hopkins Kimmel Cancer Center researchers show how a triple-drug cocktail can shrink triple-negative breast cancers by killing off cancer cells and halting new tumor growth.

20 May 2016

Study examines effects of ultra-low doses of glyphosate on gene expression profiles

Glyphosate, often sold under the brand name of Roundup, is the world's most widely used weed-killer. While Glyphosate has approval from regulatory bodies worldwide, there are growing concerns about its possible adverse health effects.

20 May 2016

Researchers identify low MCJ expression as marker of poor response to chemotherapy

Chemotherapy is a key part of the standard treatment regimen for triple-negative breast cancer patients whose cancer lacks expression of estrogen and progesterone receptors and the human epidermal growth factor receptor 2 (HER2).

20 May 2016

Loss of HOXA5 protein may allow breast cancer cells to thrive

Many breast cancers are marked by a lack of HOXA5 protein, a gene product known to control cell differentiation and death, and lower levels of the protein correspond to poorer outcomes for patients.

20 May 2016

Natural proteins could be used to test new replacement hip, knee joints

A new study suggests that natural proteins can be used to effectively test new replacement hip and knee joints in the laboratory. The work could help with improving design in order to reduce wear and tear and increase the lifespan of such prosthetics.

20 May 2016

Borrowed immune system may help combat cancer

A new step in cancer immunotherapy: researchers from the University of Oslo/Oslo University Hospital and the Netherlands Cancer Institute show that even if one's own immune cells cannot recognize and fight their tumors, someone else's immune cells might.

20 May 2016

OpenZika project uses supercomputing power to identify potential drug candidates to cure Zika virus

Rutgers is taking a leading role in an IBM-sponsored World Community Grid project that will use supercomputing power to identify potential drug candidates to cure the Zika virus.

19 May 2016

Nanoparticle-based gene therapy may hold promise for patients with asthma

A new study has demonstrated a way to deliver a nanoparticle-based gene therapy, in order to repair lungs damaged by chronic allergic asthma and to reduce inflammation that causes asthma attacks.

19 May 2016

Penn State researchers link mutation in common virus to fatal brain disease

Why people on immunosuppressant drugs for autoimmune conditions have a higher incidence of an often-fatal brain disease may be linked to a mutation in a common virus, according to researchers at Penn State College of Medicine.

19 May 2016

Higher adolescent intake of saturated fat linked to higher dense breast volume in early adulthood

Consuming high amounts of saturated fat or low amounts of mono- and polyunsaturated fats as an adolescent was associated with higher breast density in young adulthood. Breast density is a risk factor for breast cancer.

19 May 2016

New research defies earlier belief that calcium channels function independently

Voltage-gated calcium channels open in unison, rather than independently, to allow calcium ions into and activate excitable cells such as neurons and muscle cells, researchers with UC Davis Health System and the University of Washington have found.

19 May 2016

New lab blood test may help identify HELLP syndrome in pregnant women

A laboratory blood test developed at Johns Hopkins for the diagnosis of a rare genetic red blood cell disorder also shows promise in identifying HELLP syndrome, a life-threatening high blood pressure condition affecting 1 percent of all pregnant women that causes hypertension along with end organ damage, researchers report in the May issue of the journal Experimental Hematology.

19 May 2016

Study shows expression of high-affinity TCRs linked with spontaneous control of HIV infection

A small number of patients infected by HIV spontaneously control viral replication without antiretroviral therapy, and do not develop the disease. The ability of these rare patients, known as "HIV controllers", to suppress HIV replication appears to be down to a highly effective immune response.

19 May 2016

Fluorescent proteins help trace viral infections

Researchers at Umea University have developed a new method to directly follow viral infections in living organisms. This method can make infected cells produce fluorescent proteins, which means that they light up and become easier to identify.

19 May 2016

Tecentriq drug gets FDA approval to treat urothelial carcinoma

The U.S. Food and Drug Administration today approved Tecentriq (atezolizumab) to treat the most common type of bladder cancer, called urothelial carcinoma. This is the first product in its class (PD-1/PD-L1 inhibitors) approved to treat this type of cancer.

19 May 2016

ProBioGen will license GlymaxX® to Thermo Fisher Scientific for use in developing allergy diagnostics

ProBioGen, a leading specialist for contract development and manufacturing of complex glycoproteins and corresponding technologies, today announced that Thermo Fisher Scientific has licensed its GlymaxX® technology for use in development of allergy diagnostics.

19 May 2016

Domestic water hardness linked to eczema risk in children

High levels of water hardness in the home may be linked to the development of eczema early in life, according to a new study led by King's College London.

18 May 2016

Maintaining balance of P1 and P2 isoforms vital for reducing colon cancer, colitis risk

Inflammatory bowel disease (IBD), of which Crohn's disease and ulcerative colitis are the main types, is on the increase in the United States, affecting more than 1.6 million people and explaining perhaps the increase in advertisements offering treatments and cures.

18 May 2016

Crtc switch activated during fasting helps halt spread of intestinal bacteria into bloodstream

A molecular pathway that is activated in the brain during fasting helps halt the spread of intestinal bacteria into the bloodstream, according to a new study by a team of researchers at the Salk Institute.

18 May 2016

G Protein News and Research

Distek launches BIOne benchtop scale single-use bioreactor system

EAD therapy can shrink size of triple-negative breast cancer tumors in mice

Study examines effects of ultra-low doses of glyphosate on gene expression profiles

Researchers identify low MCJ expression as marker of poor response to chemotherapy

Loss of HOXA5 protein may allow breast cancer cells to thrive

Natural proteins could be used to test new replacement hip, knee joints

Borrowed immune system may help combat cancer

OpenZika project uses supercomputing power to identify potential drug candidates to cure Zika virus

Nanoparticle-based gene therapy may hold promise for patients with asthma

Penn State researchers link mutation in common virus to fatal brain disease

Higher adolescent intake of saturated fat linked to higher dense breast volume in early adulthood

New research defies earlier belief that calcium channels function independently

New lab blood test may help identify HELLP syndrome in pregnant women

Study shows expression of high-affinity TCRs linked with spontaneous control of HIV infection

Fluorescent proteins help trace viral infections

Tecentriq drug gets FDA approval to treat urothelial carcinoma

ProBioGen will license GlymaxX® to Thermo Fisher Scientific for use in developing allergy diagnostics

Domestic water hardness linked to eczema risk in children

Maintaining balance of P1 and P2 isoforms vital for reducing colon cancer, colitis risk

Crtc switch activated during fasting helps halt spread of intestinal bacteria into bloodstream

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News